|
Volumn 144, Issue 3, 2006, Pages 223-
|
Liver transplantation in HIV-seropositive individuals [11]
a a a b c d d e f |
Author keywords
[No Author keywords available]
|
Indexed keywords
COST EFFECTIVENESS ANALYSIS;
FOLLOW UP;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LETTER;
LIVER FAILURE;
LIVER TRANSPLANTATION;
MEDICAL SOCIETY;
PRIORITY JOURNAL;
SCORING SYSTEM;
SEROLOGY;
SURVIVAL RATE;
DRUG CONTRAINDICATION;
HIGHLY ACTIVE ANTIRETROVIRAL THERAPY;
NOTE;
ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE;
HIV SEROPOSITIVITY;
HUMANS;
LIVER FAILURE;
LIVER TRANSPLANTATION;
|
EID: 33644850422
PISSN: 00034819
EISSN: None
Source Type: Journal
DOI: 10.7326/0003-4819-144-3-200602070-00024 Document Type: Letter |
Times cited : (5)
|
References (5)
|